{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:59:00Z","timestamp":1789779540090,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.neuropharm.2012.11.017","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T23:05:13Z","timestamp":1354403113000},"page":"115-126","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-\u03b1 receptor activation in a genetic model of absence epilepsy"],"prefix":"10.1016","volume":"69","author":[{"given":"Rita","family":"Citraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Scicchitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina M.","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Cosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Avagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"van Luijtelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.11.017_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoylglicerol cannabinoid activity","volume":"353","author":"Ben Shabat","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib2","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1523\/JNEUROSCI.17-04-01226.1997","article-title":"Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain","volume":"17","author":"Cadas","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","article-title":"Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide","volume":"419","author":"Calignano","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1023\/A:1026179013847","article-title":"Genetic animal models for absence epilepsy: a review of the WAG\/Rij strain of rats","volume":"33","author":"Coenen","year":"2003","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjp.0704466","article-title":"Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat","volume":"135","author":"Conti","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/jpet.107.123265","article-title":"Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice","volume":"322","author":"D'Agostino","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.04.022","article-title":"Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappa B nuclear signalling in dorsal root ganglia","volume":"613","author":"D'Agostino","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib10","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease","volume":"37","author":"D'Agostino","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neuropharm.2005.01.001","article-title":"Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies","volume":"48","author":"Darmani","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2011.11.034","article-title":"Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity","volume":"676","author":"de Novellis","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(01)02934-9","article-title":"Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors","volume":"506","author":"De Petrocellis","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib14","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1523\/JNEUROSCI.23-15-06264.2003","article-title":"Peroxisome proliferator-activated receptor-a activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment","volume":"23","author":"Deplanque","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib15","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/jm00089a018","article-title":"A\u00a0novel probe for the cannabinoid receptor","volume":"35","author":"Devane","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0304-3959(01)00419-5","article-title":"Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB1 and CB2-like receptors","volume":"97","author":"Farquhar-Smith","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib17","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1523\/JNEUROSCI.23-21-07767.2003","article-title":"Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility","volume":"23","author":"Franklin","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuropharm.2005.04.012","article-title":"Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG\/Rij rats and lh\/lh mice)","volume":"49","author":"Gareri","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2009.11.069","article-title":"Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke","volume":"166","author":"Garg","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0022-3565(24)35367-4","article-title":"Cloning and pharmacological characterization of the rat cb(2) cannabinoid receptor","volume":"292","author":"Griffin","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2009.10.013","article-title":"Localized cortical injections of ethosuximide suppress spike-and-wave activity and reduce the resistance to kindling in genetic absence epilepsy rats (GAERS)","volume":"89","author":"G\u00fclhan Aker","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib23","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1523\/JNEUROSCI.1097-08.2008","article-title":"Intra-amygdaloid injection of kainic acid in rats with genetic absence epilepsy: the relationship of typical absence epilepsy and temporal lobe epilepsy","volume":"28","author":"Gurbanova","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0006-2952(97)00396-1","article-title":"Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity","volume":"55","author":"Hansen","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u2018Entourage\u2019 effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib26","first-page":"991","article-title":"Neuronal circuitry of thalamocortical epilepsy and mechanisms of antiabsence drug action","volume":"79","author":"Huguenard","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","article-title":"The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain","volume":"76","author":"Jaggar","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib28","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/00001756-199412000-00019","article-title":"Localization of the peroxisome proliferator-activated receptor in the brain","volume":"5","author":"Kainu","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12640-010-9166-2","article-title":"Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-\u03b1","volume":"19","author":"Koch","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib30","doi-asserted-by":"crossref","first-page":"23278","DOI":"10.1074\/jbc.M201084200","article-title":"15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist","volume":"277","author":"Kozak","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/0929867306666220401153732","article-title":"The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?","volume":"6","author":"Lambert","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1388-1981(99)00132-8","article-title":"Analogues and homologues of N-palmitoylethanolamide: a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors","volume":"1440","author":"Lambert","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1528-1157.2001.41499.x","article-title":"Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice","volume":"42","author":"Lambert","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/0929867023370707","article-title":"The palmitoylethanolamide family: a new class of anti-inflammatory agents?","volume":"9","author":"Lambert","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tins.2010.06.004","article-title":"BK channel activation: structural and functional insights","volume":"33","author":"Lee","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib36","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.lfs.2005.05.012","article-title":"The search for the palmitoylethanolamide receptor","volume":"77","author":"Lo Verme","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of Palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib38","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha","volume":"319","author":"LoVerme","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib40","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2007.05.015","article-title":"Microglia produce and hydrolyze palmitoylethanolamide","volume":"54","author":"Muccioli","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1476-511X-9-47","article-title":"Possible Anandamide and Palmitoylethanolamide involvement in human stroke","volume":"9","author":"Naccarato","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors","volume":"152","author":"O'Sullivan","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","article-title":"Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease","volume":"215","author":"O'Sullivan","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1528-1167.2007.01303.x","article-title":"The effect of generalized absence seizures on the progression of kindling in the rat","volume":"5","author":"Onat","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib47","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib48","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biochi.2010.01.006","article-title":"N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities","volume":"92","author":"Petrosino","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tvjl.2005.10.003","article-title":"Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals","volume":"173","author":"Re","year":"2007","journal-title":"Vet. J."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuropharm.2012.06.039","article-title":"Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity","volume":"64","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yebeh.2008.04.018","article-title":"Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy","volume":"13","author":"Russo","year":"2008","journal-title":"Epilepsy. Behav."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2012.09.019","article-title":"mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib53","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1528-1167.2011.03112.x","article-title":"Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model","volume":"52","author":"Russo","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib54","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neuropharm.2003.11.028","article-title":"Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy","volume":"46","author":"Russo","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib55","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2008.09.019","article-title":"Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia","volume":"1240","author":"Schomacher","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib57","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.yebeh.2009.08.009","article-title":"Amygdala volumes in childhood absence epilepsy","volume":"16","author":"Schreibman Cohen","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib58","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.0013-9580.2004.16604.x","article-title":"Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid","volume":"45","author":"Sheerin","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.017_bib59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jm960752x","article-title":"Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor","volume":"40","author":"Sheskin","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib60","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.93.9.3984","article-title":"The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons","volume":"93","author":"Skaper","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib62","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.bjp.0707478","article-title":"Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism","volume":"152","author":"Sun","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib63","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1042\/BST0341095","article-title":"Cannabinoids and PPARalpha signalling","volume":"34","author":"Sun","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.11.017_bib64","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1528-1167.2009.02510.x","article-title":"WAG\/Rij rats show a reduced expression of CB1 receptors in thalamic nuclei and respond to the CB1 receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges","volume":"51","author":"van Rijn","year":"2010","journal-title":"Epilepsia"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T01:28:16Z","timestamp":1745371696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812005643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":64,"alternative-id":["S0028390812005643"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.11.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}